Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use

L. R. L. Lohmer, M. K. Greenwald, R. Kakar, C. M. Laffont

Open source

DOI
10.3389/fphar.2026.1839067
Published
2026-09-08
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1839067,
  title = {Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use},
  author = {L. R. L. Lohmer and M. K. Greenwald and R. Kakar and C. M. Laffont},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1839067},
  url = {https://doi.org/10.3389/fphar.2026.1839067}
}

RIS

TY  - JOUR
TI  - Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use
AU  - L. R. L. Lohmer
AU  - M. K. Greenwald
AU  - R. Kakar
AU  - C. M. Laffont
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1839067
UR  - https://doi.org/10.3389/fphar.2026.1839067
ER  - 

APA

Lohmer, L. R. L., Greenwald, M. K., Kakar, R., & Laffont, C. M. (2026). Optimal buprenorphine exposure to treat patients with opioid use disorder in the era of fentanyl and polysubstance use. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1839067

Source records